DEXCOM, INC. Debt Securities, Available-for-sale, Noncurrent
DEXCOM, INC. (DXCM) had Debt Securities, Available-for-sale, Noncurrent of $236.80 million as of 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2025-05-01
- 2025-03-31: Debt Securities, Available-for-sale, Noncurrent $236.80M.
- 2024-12-31: Debt Securities, Available-for-sale, Noncurrent $247.70M.
- 2024-09-30: Debt Securities, Available-for-sale, Noncurrent $217.30M.
- 2024-06-30: Debt Securities, Available-for-sale, Noncurrent $156.40M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2025-03-31 | $236.80M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $247.70M 10-Q · filed 2025-05-01 |
| 2024-09-30 | $217.30M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $156.40M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $275.60M 10-Q · filed 2024-04-25 |
| 2022-03-31 | $99.20M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $320.70M 10-K · filed 2023-02-09 |
| 2021-09-30 | $169.90M 10-Q · filed 2021-10-28 |
| 2018-12-31 | $14.40M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |